Search results for "Rate ratio"

showing 10 items of 48 documents

Sex- and age patterns in incidence of infectious diseases in Germany: analyses of surveillance records over a 13-year period (2001–2013)

2018

AbstractSex differences in the incidence of infections may indicate different risk factors and behaviour but have not been analysed across pathogens. Based on 3.96 million records of 33 pathogens in Germany, notified from 2001 to 2013, we applied Poisson regression to generate age-standardised incidence rate ratios and assessed their distribution across age and sex. The following trends became apparent: (a) pathogens with male incidence preponderance at infant and child age (meningococcal disease (incidence rate ratio (IRR) = 1.19, 95% CI 1.03–1.38, age = 0–4); influenza (IRR = 1.09, 95% CI 1.06–1.13, age = 0–4)), (b) pathogens with sex-switch in incidence preponderance at puberty (e.g. nor…

0301 basic medicineAdultMaleAdolescentEpidemiology030106 microbiologyGermany/epidemiologyMeningococcal diseasemedicine.disease_causeRate ratioCommunicable Diseases03 medical and health sciencessymbols.namesakeYoung Adult0302 clinical medicineSex FactorsRisk FactorsGermanymedicineHumans030212 general & internal medicinePoisson regressionYoung adultChildAgedAged 80 and overbusiness.industryCampylobacterIncidence (epidemiology)IncidenceAge FactorsInfant NewbornInfantCommunicable Diseases/epidemiologyMiddle Agedmedicine.diseaseOriginal PapersInfectious DiseasesInfectious disease (medical specialty)Child PreschoolsymbolsFemalebusinessEncephalitisDemography
researchProduct

Features associated with melanoma metastasis in Latvia

2020

Cutaneous melanoma (CM) is the most aggressive form of skin cancer, exhibits an increasing incidence worldwide and has a high potential to develop metastasis. The current study aimed to identify a set of parameters that may aid in predicting the probability and timing of the onset of CM metastasis. A retrospective analysis was performed using the archive data of 2,026 patients with CM that were treated at the Riga East University Hospital Latvian Oncology Centre, which is the largest oncological hospital in the country, between 1998 and 2015. A case-control study design was employed, where patients with metastasis (n=278) were used as the cases and patients without metastasis were used as t…

0301 basic medicineOncologyCancer Researchmedicine.medical_specialtyRate ratiosurvivalMetastasisBreslow Thickness03 medical and health sciences0302 clinical medicinepigmentInternal medicinemelanomamedicinemetastasisbusiness.industryMelanomaCancerArticlesOdds ratiomedicine.diseaseulceration030104 developmental biologyOncology030220 oncology & carcinogenesisCutaneous melanomaprognosisSkin cancerbusinessBreslow thicknessOncology Letters
researchProduct

High-sensitivity troponin T and the risk of recurrent readmissions after hospitalization for acute heart failure

2017

Abstract Objectives High-sensitivity troponin is a biomarker of myocardial damage and is associated with a greater risk of mortality and disease progression in patients with acute heart failure (AHF). However, its relationship with the risk of future readmissions is less known. The aim of this study was to assess the association between ultrasensitive troponin T (TnT-us) values in patients with AHF and the risk of recurrent readmissions in the follow-up. Methods We prospectively included a cohort of 621 consecutive patients with AHF, excluding those patients with acute coronary syndrome. We measured the TnT-us levels obtained during the first medical contact in the emergency department. The…

Acute coronary syndromemedicine.medical_specialtybiologyTroponin Tbusiness.industryGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseRate ratioTroponin03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicineHeart failureCohortmedicineRisk of mortalitybiology.proteinCardiology030212 general & internal medicinebusinessRevista Clínica Española (English Edition)
researchProduct

Mid-term trends and recent birth-cohort-dependent changes in incidence rates of cutaneous malignant melanoma in Italy

2020

In Oceania, North America and north-western Europe, after decades of increase, cutaneous malignant melanoma (CMM) rates began to stabilise or decline before 2000. Anecdotal evidence suggests that the reversal of the incidence trend is extending to southern Europe. To obtain a formal confirmation, this nationwide study from Italy investigated the incidence trends by birth cohort. Twenty-one local cancer registries covering a population of 15 814 455 provided incidence data for primary CMM registered between 1994 and 2013. Trends in age-standardised rates were analysed using joinpoint regression models and age-period-cohort models. Age-standardised incidence showed a consistent increase throu…

AdultMaleCancer ResearchSkin NeoplasmsAdolescentAge-period-cohort modelling birth cohort cutaneous malignant melanoma incidence time trendPopulationSocio-culturaleRate ratioSettore MED/42 - Igiene Generale E ApplicataRisk AssessmentYoung Adult03 medical and health sciences0302 clinical medicineage-period-cohort modellingHumansMedicineRegistrieseducationMelanomaAgedAged 80 and overeducation.field_of_studyGeographybusiness.industryIncidence (epidemiology)Melanomabirth cohortMiddle Agedmedicine.diseaseConfidence intervalAnnual Percent Changetime trendItalyOncology030220 oncology & carcinogenesisCohortincidenceFemalebusinessBirth cohortcutaneous malignant melanomaDemography
researchProduct

Type of retirement as a determinant of pre- and post-retirement hospital in-patient care use: a prospective study

2014

Background We examined prospectively the use of all-cause hospital in-patient care among public sector employees by using a 3-year pre- and post-retirement study window. Methods A total of 5269 participants of the Finnish Longitudinal Study of Municipal Employees had retired during January 1984 and July 2000. They had register-based data on retirement (non-disability retirement n = 3411, men 40%, and diagnose-specific disability retirement n = 1858, men 50%) and all-cause hospital in-patient admissions and discharges. Analyses were conducted using Generalized Estimating Equation model. Results The prevalence of hospital care use for non-disability retirees remained stable during the 6-year …

AdultMaleGerontologymedicine.medical_specialtyLongitudinal studyDiseaseRate ratiomedicineHumansIn patientProspective StudiesPsychiatryProspective cohort studyGeneralized estimating equationFinlandPublic Sectorbusiness.industryagingPublic sectorPublic Health Environmental and Occupational Healthta3142General MedicineMiddle AgedHospital careHospitalizationretirementFemalebusinesshospital careJournal of Public Health
researchProduct

Body size at birth and coronary heart disease-related hospital care in adult men : Findings from the Helsinki Birth Cohort Study

2017

Aim: We investigated, among those who had been hospitalized at least once due to coronary heart disease (CHD), the relationship between ponderal index (PI, birthweight/length3) at birth, a measure of thinness, and the age at first hospitalization due to CHD, the number of CHD-related hospital care episodes, and cost of CHD-related hospital care from young adulthood to old age. Methods and results: Data from the Helsinki Birth Cohort Study included 964 men born in Helsinki, Finland during 1934–1944, who had been hospitalized due to CHD and had birth anthropometrics data. PI (kg/m3) was categorized into low (27.5). CHD-related hospital care data were available from 1971 to 2013. We observed a…

AdultMalePediatricsmedicine.medical_specialtyBirth weightCoronary Disease030204 cardiovascular system & hematologyRate ratioCohort Studies03 medical and health sciences0302 clinical medicineage of onsetThinnesscardiovascular disease030225 pediatricsPrevalenceBirth WeightBody SizeHumansMedicinecardiovascular diseasesYoung adultcoronary heart diseaseFinlandbusiness.industryagingta3141General Medicineta3142AnthropometryConfidence intervalCoronary heart disease3. Good healthHospitalizationbirthweightAge of onsetbusinessCohort studyAnnals of Medicine
researchProduct

Omalizumab and the risk of malignancy: results from a pooled analysis.

2011

Background Since initial registration, the omalizumab clinical trial database has expanded considerably, with a doubling of patients exposed in the clinical trial environment. Previous pooled data (2003) from phase I to III studies of omalizumab showed a numeric imbalance in malignancies arising in omalizumab recipients (0.5%) compared with control subjects (0.2%). The previous analysis was based on limited available data, warranting further investigation. Objective We sought to examine the incidence of malignancy using comprehensive pooled data from clinical trials of omalizumab-treated patients. Methods This pooled analysis included data from 67 phase I to IV clinical trials. The prespeci…

AdultMaleRiskmedicine.medical_specialtyAdolescentImmunologyOmalizumabOmalizumabRate ratioMalignancyAntibodies Monoclonal HumanizedYoung AdultInternal medicineNeoplasmsImmunology and AllergyMedicineHumansAnti-Asthmatic AgentsYoung adultAdverse effectChildAsthmaAgedAged 80 and overbusiness.industryIncidence (epidemiology)IncidenceAntibodies MonoclonalMiddle Agedmedicine.diseaseSurgeryAntibodies Anti-IdiotypicClinical trialChild PreschoolFemalebusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Associations between cataract and multimorbidity: a cross-sectional study of 23,089 adults from Spain

2020

Background: Little is known about the association between cataract and multimorbidity. Therefore, the aim of the present study was to examine the relationship between cataract and chronic conditions and multimorbidity in a large representative sample of Spanish adults. Methods: This study used data from the Spanish National Health Survey 2017, a cross-sectional sample of 23,089 adults aged ≥15 years from Spain [54.1% female; mean (standard deviation) age 53.4 (18.9) years]. Cataract and 30 other physical and mental chronic conditions were self-reported. Multimorbidity was defined as the presence of at least two physical and/or mental chronic conditions (excluding cataract). Control variable…

AdultMalegenetic structuresmultimorbidityCross-sectional study[SDV]Life Sciences [q-bio]PopulationPsychological interventionRate ratioCataractArticle03 medical and health sciences0302 clinical medicinePrevalenceHumansMedicineMultimorbidity030212 general & internal medicineeducationeducation.field_of_studybusiness.industryMultimorbidityOdds ratioMiddle AgedConfidence intervaleye diseases3. Good healthOphthalmologynot availableCross-Sectional StudiesSpaincataractChronic Disease030221 ophthalmology & optometryMarital statusFemalebusinessDemography
researchProduct

Prospective, Single-Arm, Longitudinal Study of Biomarkers in Real-World Patients with Severe Asthma.

2019

ARIETTA was a prospective, single-arm, noninterventional, multicenter study in patients with severe asthma.To examine the predictive and prognostic abilities of type 2 biomarkers for severe asthma outcomes.Adult patients with severe asthma receiving daily inhaled corticosteroids (fluticasone propionate ≥500 μg or equivalent) and ≥1 second controller medication were enrolled. Biomarker, clinical, and safety data were collected over 52 weeks. The primary endpoint was the asthma exacerbation rate over 52 weeks in serum periostin-high (≥50 ng/mL at baseline) versus periostin-low subgroups (50 ng/mL). Correlations between biomarker levels (periostin, blood eosinophils, IgE, and fractional exhale…

AdultMalemedicine.medical_specialtyExacerbationRate ratioImmunoglobulin ENitric OxideGastroenterologyFluticasone propionate03 medical and health sciences0302 clinical medicineInterquartile rangeInternal medicinemedicineClinical endpointImmunology and AllergyHumans030212 general & internal medicineLongitudinal StudiesProspective Studiesbiologybusiness.industryConfidence intervalAsthma3. Good healthEosinophils030228 respiratory systembiology.proteinBiomarker (medicine)FemalebusinessBiomarkersmedicine.drugThe journal of allergy and clinical immunology. In practice
researchProduct

Low incidence of psychosis in Italy: confirmation from the first epidemiological study in Sicily

2017

Purpose: The incidence of psychotic disorders varies in different geographical areas. As there have been no reports from Southern Italy, this study aimed to determine the incidence rate of first-episode psychosis in Palermo, Sicily. Methods: All patients, aged 18–65 years, presenting with a first episode of psychosis (FEP) (ICD-10 F20–29, F30–33) to mental health services in Palermo, were recorded over a 3-year period. Incidence rates of psychotic disorders and their 95% confidence intervals (95% CI) were estimated. Poisson regression was applied to estimate the differences in incidence rate ratio (IRR) by age, sex and migrant status. Results: Two hundred and four FEP participants were iden…

AdultMalemedicine.medical_specialtyHealth (social science)AdolescentSocial PsychologyEpidemiologyPsychosiRate ratioArticleYoung Adult03 medical and health sciencessymbols.namesake0302 clinical medicineEpidemiologySettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.medicineHumansPoisson regressionPsychiatrySettore MED/25 - PsichiatriaSicilyAgedFirst episodebusiness.industryIncidenceIncidence (epidemiology)Middle AgedPsychosismedicine.diseaseConfidence interval030227 psychiatryEpidemiologic StudiesPsychiatry and Mental healthItalyPsychotic DisordersSchizophreniaSchizophreniaEtiologysymbolspopulation characteristicsFemalebusinessSettore M-PSI/05 - Psicologia Sociale030217 neurology & neurosurgeryDemographySocial Psychiatry and Psychiatric Epidemiology
researchProduct